Global Pulmonary Drug Delivery Systems Market 2012-2016

Share Article

Reportbuyer.com just published a new market research report: Global Pulmonary Drug Delivery Systems Market 2012-2016.

TechNavio's analysts forecast the Global Pulmonary Drug Delivery Systems market to grow at a CAGR of 14.47 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of lung-related or respiratory diseases. The Global Pulmonary Drug Delivery Systems market has also been witnessing an increasing adoption of online marketing strategy. However, intense competition among vendors could pose a challenge to the growth of this market.

TechNavio's report, the Global Pulmonary Drug Delivery Systems Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global Pulmonary Drug Delivery Systems market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space 3M Healthcare Ltd., AstraZeneca plc, GlaxoSmithKline plc, and Sunovion Pharmaceuticals Inc.

The other vendors mentioned in this report are Akela Pharma Inc., Alkermes Inc., Allied Healthcare Products Inc., Boehringer Ingelheim GmbH, CareFusion Corp., Chiesi Farmaceutici S.p.A., Dainippon Sumitomo Pharma Co. Ltd., GF Health Products Inc., Novartis AG, PARI Respiratory Equipment Inc., Philips Respironics Inc., Omron Healthcare Co. Ltd., SkyePharma plc, and Vectura Group plc.

Key questions answered in this report:

What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

Methodology

Research methodology is based on extensive primary and secondary research. Primary research includes in-depth interviews with industry experts, vendors, resellers and customers. Secondary research includes Technavio Platform, industry publications, company reports, news articles, analyst reports, trade associations and the data published by Government agencies.
01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Market Size and Forecast
Market Segmentation
06.2 Global MDI Market
Market Size and Forecast
06.3 Global DPI Market
Market Size and Forecast
06.4 Global Nebulizer Market
Market Size and Forecast
06.5 Five Forces Analysis
07. Geographical Segmentation
08. Rate of Incidence and Prevalence
09. Vendor Landscape
Product Portfolio Matrix
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1 AstraZeneca plc
Business Overview
Key Information
SWOT Analysis
GlaxoSmithKline plc
Business Overview
Key Information
SWOT Analysis
16.2 Sunovion Pharmaceuticals Inc.
Business Overview
Key Information
SWOT Analysis
16.3 3M Healthcare Ltd.
Business Overview
Key Information
SWOT Analysis
17. Other Reports in this Series

List of Exhibits

Exhibit 1: Market Research Methodology
Exhibit 2: Global Pulmonary Drug Delivery Systems Market 2012-2016 (US$ billion)
Exhibit 3: Global Pulmonary Drug Delivery Systems Market Segmentation
Exhibit 4: Global Pulmonary Drug Delivery Systems Market Segmentation 2012
Exhibit 5: Global Metered Dose Inhalers Market 2012-2016 (US$ billion)
Exhibit 6: Global Dry Powder Inhalers Market 2012-2016 (US$ billion)
Exhibit 7: Global Nebulizer Market 2012-2016 (US$ million)
Exhibit 8: Global Pulmonary Drug Delivery Systems Market by Geographical Segmentation 2012
Exhibit 9: Business Segmentation of GlaxoSmithKline plc
Exhibit 10: Business Segmentation of Sunovion Pharmaceuticals Inc

Companies Mentioned

3M Healthcare Ltd., AstraZeneca plc, GlaxoSmithKline plc, Sunovion Pharmaceuticals Inc., Akela Pharma Inc., Alkermes Inc., Allied Healthcare Products Inc., Boehringer Ingelheim GmbH, CareFusion Corp., Chiesi Farmaceutici S.p.A., Dainippon Sumitomo Pharma Co. Ltd., GF Health Products Inc., Novartis AG, PARI Respiratory Equipment Inc., Philips Respironics Inc., Omron Healthcare Co. Ltd., SkyePharma plc, and Vectura Group plc.

Read the full report:

Global Pulmonary Drug Delivery Systems Market 2012-2016

http://www.reportbuyer.com/pharma_healthcare/drug_delivery/global_pulmonary_drug_delivery_systems_market_2012_2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah Smith
Research Advisor at Reportbuyer.com
+44 208 816 85 48
Email >
Visit website